Atlas Trials

Vyvanse and Glucose Intolerance in Children With Attention Deficit Hyperactivity Disorder (ADHD) and Obesity

Clinical trial NCT01017263 · TERMINATED

Trial details

NCT number
NCT01017263
Sponsor
Duke University
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Attention Deficit Hyperactivity DisorderGlucose IntoleranceObesity
Start date
2009-12-01
Primary completion
2012-08-01
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.